Joining me on today's call are Chief Executive Officer, Bryan C. Hanson, and Chief Financial Officer, Wayde D. McMillan.

Feb 26 (Reuters) - Medical device maker Solventum on Thursday beat Wall Street estimates for the fourth quarter, helped by strong demand for its wound care and sterilization products. The ...

Solventum reported $2 billion in Q4 sales, a 3.5% increase on an organic basis, beating market expectations of $1.96 billion.

Healthcare solutions provider Solventum (NYSE:SOLV) announced in Q4 CY2025, but sales fell by 3.7% year on year to $2.00 ...

The average estimate of six analysts surveyed by Zacks Investment Research was for earnings of $1.50 per share. The health care company posted revenue of $2 billion in the period, also exceeding ...

SOLV readies Q4 results amid solid momentum, tariff headwinds, and M&A focus as investors watch margins and growth trends ...

Analysts expect earnings of $1.75 per share, representing a 24% increase from the year-ago period and a 17% sequential improvement from the third quarter, when Solventum missed expectations with $1.50 ...

Solventum (NYSE: SOLV) today reported financial results for the fourth quarter and year ended December 31, 2025.

Solventum, a leader in healthcare technology and speech recognition documentation, announced its official designation as an Accelerator partner in the MEDITECH Alliance. Through this partnership, the ...

It’s been almost a year since Solventum spun off as a separate business from 3M. Now, Solventum is orchestrating a spinoff of its own. On Tuesday, Solventum announced that it has lined up a deal to ...

With a market cap of $11.5 billion, Solventum Corporation (SOLV) is a U.S.-based healthcare company that was spun off from 3M on April 1, 2024. Headquartered in Maplewood, Minnesota, Solventum focuses ...

The need for autonomous coding solutions is multi-faceted and increasing. This need stems mainly from a shortage of qualified coding resources, staggering numbers of patient charts to code, constantly ...